There is an increasing interest in the potential clinical application
of xenotransplantation. This interest derives in part from the need to
identify a more abundant source of organs for transplantation and in
part from rapid progress in understanding the cellular and molecular c
hanges that contribute to hyperacute and acute vascular xenograft reje
ction. Recent areas of progress in understanding the immunological hur
dles to xenotransplantation include the characterization of xenoreacti
ve antibodies and the antigens they recognize, the role of complement
regulatory proteins in immune recognition, the mechanism of complement
activation in a xenograft, and the pathophysiologic changes in endoth
elial cells caused by the activation of complement.